LifeStance Health Group, Inc.
NASDAQ Global SelectRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- LifeStance Health Group, Inc. (LFST) provides outpatient mental health services to children, adolescents, adults, and geriatrics across the United States through a network of approximately 550 centers in 33 states; core offerings include psychiatric evaluations and treatment, psychological and neuropsychological testing, individual, family, and group therapy, psychotherapy, medication management, children and adolescent services, women's services, testing and evaluation, specialty treatments such as TMS and ketamine therapies, and addiction treatment, delivered via hybrid in-person and telehealth platforms treating conditions including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Founded in 2017 and headquartered in Scottsdale, Arizona, the company operates a single reportable segment focused on mental health services, accepts over 300 insurances, and employs approximately 7,500 to 8,000 clinicians. Recent developments include a partnership with Calm Health announced in October 2025 to streamline access to licensed mental health clinicians for app users, a $100,000 grant and year-long collaboration with the American Foundation for Suicide Prevention in September 2025 supported by employee donation matching, completion of a $390 million senior secured credit facilities refinancing in October 2025 to replace prior private credit structures, rebranding of local practices such as Child & Family to the unified LifeStance Health name, plans for 20 to 25 new center openings by end-2025, addition of 288 net new clinicians in Q3 2025 for an 11% increase to 7,996 total, achievement of a second consecutive quarter of positive net income and Adjusted EBITDA margins of 11% in Q3 2025, and signals of disciplined mergers and acquisitions including potential tuck-in deals, digital therapeutics, and specialty services for 2025 and beyond following efficiency improvements and free cash flow positivity.
Company News
LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026
Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
Nearly Half of Americans Say Fear of an Unwanted Viral Moment Keeps Them from Being Themselves in Public, LifeStance Survey Finds
LifeStance Health CTO Sells 42,067 Shares for $541,402
74,169 Shares in LifeStance Health Group, Inc. $LFST Bought by HighTower Advisors LLC
LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Analyzing Mangoceuticals (NASDAQ:MGRX) and LifeStance Health Group (NASDAQ:LFST)
Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
5 Low-Leverage Stocks to Buy Amid Rising Oil Prices & Inflation Woes
LifeStance Health Group Announces Pricing of Secondary Public Offering
LifeStance Health Group Announces Launch of Secondary Public Offering
LifeStance Health Group, Inc. (LFST) Hit a 52 Week High, Can the Run Continue?
LifeStance to Present at Upcoming Investor Conferences
Canada Pension Plan Investment Board Makes New Investment in LifeStance Health Group, Inc. $LFST
4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds
Bet on These 5 Low-Leverage Stocks as Bond Yields Dip
LifeStance Health Group (LFST) Is Up 3.44% in One Week: What You Should Know
5 Low-Leverage Stocks to Buy as High Oil Prices Shake Investor Confidence
LifeStance Health (LFST) Upgraded to Buy: Here's Why
LifeStance Health Group, Inc. (LFST) Soars to 52-Week High, Time to Cash Out?